Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Operating Expenses | 14,273 | 11,397 | 7,138 | 7,091 | 7,040 |
| Operating Income | -14,273 | -11,397 | -7,138 | -7,091 | -7,040 |
| Other Income | 172 | 149 | 54 | -7 | -4,707 |
| Pre-tax Income | -14,101 | -11,248 | -7,084 | -7,098 | -11,747 |
| Net Income Continuous | -14,101 | -11,248 | -7,084 | -7,098 | -11,747 |
| Net Income | $-14,101 | $-11,248 | $-7,084 | $-7,098 | $-11,747 |
| EPS Basic Total Ops | -0.84 | 55.10 | -0.87 | -19.07 | -40.96 |
| EPS Basic Continuous Ops | -0.84 | 54.39 | -0.84 | -18.49 | -40.79 |
| EPS Diluted Total Ops | -0.84 | 55.10 | -0.87 | -19.07 | -40.96 |
| EPS Diluted Continuous Ops | -0.84 | 54.39 | -0.84 | -18.49 | -40.79 |
| EBITDA(a) | $-14,063 | $-11,287 | $-7,045 | $-7,015 | $-6,885 |